Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck Looks Past Medicare: Next Up, Covering The Uninsured

Executive Summary

Merck is preparing for what it believes should be the next big health care policy debate in Washington after Medicare Rx legislation is enacted: health care coverage for the uninsured
Advertisement

Related Content

Zocor, Zoloft And Pravachol Will Be Key Generic Switches For Medco In ’06
Zocor, Zoloft And Pravachol Will Be Key Generic Switches For Medco In ’06
Medicare Rx Should Cover Dual-Eligibles, Merck Says; Industry Applauds Bill
Pfizer Medicare Message: “Safeguards” Critical, Rx Growth Will Follow
Medicare Rx Debate Moves Forward; Kennedy Sees Bill As “Down Payment”
Medicare Rx Debate Moves Forward; Kennedy Sees Bill As “Down Payment”
Pfizer Medicare Message: “Safeguards” Critical, Rx Growth Will Follow
Formularies Would Be Authorized But Restricted Under Senate Medicare Bill
Merck/Medco Rebate Deal Gives Merck Control Of New Managed Care Tools
Rx Market Requires “Value,” Not Sales Force Muscle, Merck’s Gilmartin Says
Advertisement
UsernamePublicRestriction

Register

PS042011

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel